Deprescribing in older adults during COVID-19 pandemic; Opportunity or risk?

Res Social Adm Pharm. 2021 May;17(5):1024-1025. doi: 10.1016/j.sapharm.2020.11.016. Epub 2020 Dec 1.
No abstract available

Keywords: Deprescribing; Frailty; Personalized medicine; Polypharmacy.

Publication types

  • Letter
  • Comment

MeSH terms

  • Aged
  • COVID-19*
  • Deprescriptions*
  • Humans
  • Inappropriate Prescribing
  • Pandemics
  • Polypharmacy
  • SARS-CoV-2